Neuropad in the news

22 Apr 2021

Coronavirus pandemic and autonomic neuropathy as an indicator of a poor outcome from Covid infection This is a recent very useful resource produced by the Foundation for Diabetes Research in Older People & RIA Diabetes and Education concerning the Vascular and Non-Vascular Complications of Diabetes and in this module neuropathy and diabetes-related foot disease in care homes residents. Slide 6 includes information on the Neuropad® test. Read the full article. ...

13:19 / Uncategorized
24 Jan 2021

A newly published article critically appraises research and clinical methods for the diagnosis or screening of early DPN. In brief, functional measures are subjective and are difficult to implement due to technical complexity. Moreover, skin biopsy is invasive, expensive and lacks diagnostic laboratory capacity. Indeed, point-of-care nerve conduction tests are convenient and easy to implement however questions are raised regarding their suitability for use in screening due to the lack of small nerve fibre evaluation. The signs and symptoms of DPN are insidious and current screening programmes rely on subjective tests...

13:20 / Uncategorized
12 Nov 2019

A new study examines the cost effectiveness of the Neuropad screening test for diabetic neuropathy vs the 10g mononfilament test and also in combination with the 10g monofilament. Compared with standard care, Neuropad, in combination with the 10-g monofilament tool, is the dominant strategy as it leads to higher health gains and lower costs. In practice, compared with using the monofilament alone, performing both tests would lead to a savings of £1049.26 per patient and 0.044 QALY gain. Results were found to be consistent across the sensitivity analyses. The authors concluded that using...

13:21 / Uncategorized
28 Aug 2018

As part of its ongoing Neuropad guidance development, the UK National Institute of Health and Care Excellence (NICE) commissioned an Adoption Scoping Report. In the report, NICE asked NHS clinicians who were familiar with the Neuropad test what they thought of it. Amongst the comments received, the principal findings were as follows: ‘Contributors thought that sweat production is a good marker of diabetic peripheral neuropathy. All reported that Neuropad could be used as part of a comprehensive foot assessment and in conjunction with sensory testing.’ Contributors went on to say that: ‘Neuropad...

13:25 / Uncategorized
09 Jul 2018

Newly published figures from the NHS England show that the weekly amputation rate has again climbed to now 169 a week and that they still show huge regional variation. This was as true in 2012 as it is today. In 2012 Diabetes UK launched its ‘Putting Feet First’ campaign but what has happened to that initiative? It seems to have all but disappeared now with a focus on blood glucose control rather than the complications associated with it yet the charity has referred to the ever increasing rate of amputations as...

15:02 / Uncategorized
10 Jun 2018

Professor Sidney Weinstein(1922-2010), an American neuropsychologist, together with psychologist Dr Josephine Semmes, developed the instrument originally referred to as the Semmes-Weinstein Pressure Aesthesiometer (SWPA), a calibrated series of nylon monofilaments inspired by the Von-Frey horse-hair instrument which permitted the quantification and classification of sensory loss in brain-injured patients. They used the monofilaments to map cortical areas of the brain in monkeys. The initial publication of normative thresholds in human subjects is found in the book Somatosensory Changes After Penetrating Brain Wounds in Man. When the US DuPont company first invented...

15:03 / Uncategorized
30 Mar 2017

Following a comprehensive initial submission and review process during 2016, culminating on the 23rd of December 2016 with a decision by the National Institute of Health and Care Excellence (NICE) Medical Technologies Advisory Committee (MTAP, the committee decided to develop new guidance for the neuropad® 10-Minute Screening Test for the early detection of diabetic neuropathy.For those that may be unfamiliar with NICE and the Medical Technologies Evaluation Programme (MTEP), the MTEP was launched in November 2009 and represents an enhancement in capacity for the evaluation of devices and diagnostic technologies....

15:04 / Uncategorized
30 Mar 2017

We are pleased to announce that customers can now purchase our neuropad 10-Minute Screening Test® and neuropad® Foot Repair Foam by clicking on the ‘Buy’ button on the main menu at the top of this and every other page on our web site. Shipping is free on bulk order (boxes of >12 tests and foam canisters) and all orders are tracked. ...

15:03 / Uncategorized
20 Mar 2017

'Products for conditions like eczema and psoriasis [and other dry skin conditions] can leave people at risk of setting themselves ablaze’ stated the BBC on the 19th of March 2017. If people use the creams regularly but do not often change clothes or bedding, paraffin residue can soak into the fabric, making it flammable. The medicines regulator [the MHRA] has updated its guidance and says all creams containing paraffin should carry a warning. Despite warnings going back more than 10 years, BBC Radio 5 live Investigates has discovered there have...

15:05 / Uncategorized
25 Feb 2017

People with diabetes are around 23 times as likely to have a leg, foot or toe amputation as those without diabetes. Approximately 8 out of every 10,000 people with diabetes undergo major lower extremity amputation (above ankle) each year, and 18 out of 10,000 have minor amputation (below ankle).A new report by Insight Health Economics: Diabetic Foot Care in England, An Economic Case Study commissioned by the charity Diabetes UK estimates that the NHS in England spent £972m – £1.13bn on healthcare related to foot ulceration and amputation in diabetes...

15:05 / Uncategorized